Markets & Stocks
Stay informed about the latest developments and trends in the cannabis stock market with Business of Cannabis. Discover new investment opportunities, market analysis, and more in our stocks category.
Markets & Stocks · page 7
- M&A Activity
Barney’s Farm Terminates Landmark Merger With Sensi Seeds & Ilgm Amid Accusations of Failed Payments
Dutch seed bank Barney’s Farm, one of the leading names in the global consumer cannabis seeds market, has backed out of a landmark merger with Sensi Seeds and US firm I Love Growing Marijuana (ILGM).
- Supply Chain
The Canadians are Coming: Europe Grapples With Growing Wave of Canadian Cannabis
Canadian cannabis exports to Europe are surging, with Tilray, High Tide and MediPharm expanding in Germany and the UK despite local pushback.
- Public Markets
Cannabis Stocks Hit Highest Point This Year on Trump Rescheduling Hopes
Cannabis stocks across North America have skyrocketed to their highest point so far this year, despite a lukewarm promise from the US President on cannabis rescheduling.
- Public Markets
A Tale of Two Markets: German Cannabis Companies Chase Records as UK Operators Seek Exits
As Q2 2025 figures continue to roll in, the stark contrast between companies operating in the UK and Germany are becoming increasingly apparent.
- Investment & Finance
New Data, New Players: Why Cannabis Pharma Deserves Investor Attention
Amid rising global scrutiny of the wider medical cannabis prescription model, and with markets like France leaning into pharmaceutical-grade regulation, the pharma cannabis sector is shaping up to be one of the most dynamic and closely watched corners of the industry.
- M&A Activity
Grow Group’s Avida Acquisition Marks Bold Step Forward for UK Cannabis Stalwart
Grow Group, one of the UK’s leading medical cannabis distributors now supplying over 10,000 patients internationally, announced a major strategic shift to bring control of its operations entirely in house.
- Investment & Finance
Cannabis Exodus from Public Markets Continues: Celadon Announces Plans to Leave AIM and IMC Fights to Remain on NASDAQ
The exodus of listed cannabis companies from the public markets, particularly in the UK, is continuing at pace as yet another medical cannabis operator has announced plans to delist.
- Companies
Pharmaceutical Cannabis Steps Into the Spotlight as DanCann, Phytanix and Sandoz Unveil Major Moves
Welcome to Business of Cannabis’ new weekly strategic digest tracking the financial health, market moves, and corporate developments shaping the European cannabis sector.
- Markets & Stocks
Argent Bio’s Stock Flies on German Approval, Jazz Hit by Tariff Barrage, & Kanabo Cautions ‘Financial Uncertainty’
Argent BioPharma [stock_market_widget type=”chart” template=”line” assets=”RGT.AX” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Argent BioPharma has managed to overcome the wider chaos on the stock markets this week, seeing its stock jump over 40% in the wake of two major announcements.
- Markets & Stocks
Ananda Gets Ethics Approval for Australian Clinical Study, Synbiotic Launches Germany’s First THC-Pastille, & More from Stenocare
UK-based cannabinoid pharmaceutical company Ananda Pharma has received ethics approval for a Phase 1 clinical study for its lead compound in Australia.
- Markets & Stocks
Celadon Announces Intention to Delist amid Exodus of Directors, Allied Corp Lays Out Future Plans, & Chill Brands Delays Financial Results Again
Celadon Pharmaceuticals [stock_market_widget type=”chart” template=”line” assets=”CEL.L” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Celadon Pharmaceuticals has become the latest major European publicly listed cannabis company to announce plans to de-list its shares from the London Stock Exchange.
- Markets & Stocks
How Will Trump’s ‘Super Bowl’ of Tariffs Impact US Cannabis
‘Liberation day’, set to take place on April 02, has been pitched as the day the Trump administration will roll out sweeping and aggressive tariffs for all of the US’ trading partners.
